U.S. flag

An official website of the United States government

NM_001378902.1(ROS1):c.3167A>G (p.Asn1056Ser) AND Lung adenocarcinoma

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Jun 6, 2022
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003129714.2

Allele description [Variation Report for NM_001378902.1(ROS1):c.3167A>G (p.Asn1056Ser)]

NM_001378902.1(ROS1):c.3167A>G (p.Asn1056Ser)

Gene:
ROS1:ROS proto-oncogene 1, receptor tyrosine kinase [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
6q22.1
Genomic location:
Preferred name:
NM_001378902.1(ROS1):c.3167A>G (p.Asn1056Ser)
HGVS:
  • NC_000006.12:g.117362802T>C
  • NG_033929.1:g.68054A>G
  • NM_001378891.1:c.3170A>G
  • NM_001378902.1:c.3167A>GMANE SELECT
  • NM_002944.3:c.3182A>G
  • NP_001365820.1:p.Asn1057Ser
  • NP_001365831.1:p.Asn1056Ser
  • NP_002935.2:p.Asn1061Ser
  • NP_002935.2:p.Asn1061Ser
  • LRG_997t1:c.3182A>G
  • LRG_997:g.68054A>G
  • LRG_997p1:p.Asn1061Ser
  • NC_000006.11:g.117683965T>C
  • NM_002944.2:c.3182A>G
Protein change:
N1056S
Molecular consequence:
  • NM_001378891.1:c.3170A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001378902.1:c.3167A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_002944.3:c.3182A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Lung adenocarcinoma
Synonyms:
Adenocarcinoma of lung; Adenocarcinoma of lung, somatic
Identifiers:
MONDO: MONDO:0005061; MeSH: D000077192; MedGen: C0152013; Human Phenotype Ontology: HP:0030078

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV003806415Liquid Biopsy and Cancer Interception Group, Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research
criteria provided, single submitter

(AMP Guidelines, 2017)		Uncertain significance
(Jun 6, 2022) 		somaticresearch

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedsomaticyes1not providednot provided1not providedresearch

Citations

PubMed

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.

Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S, Tsimberidou AM, Vnencak-Jones CL, Wolff DJ, Younes A, Nikiforova MN.

J Mol Diagn. 2017 Jan;19(1):4-23. doi: 10.1016/j.jmoldx.2016.10.002. Review.

PubMed [citation]
PMID:
27993330
PMCID:
PMC5707196

Details of each submission

From Liquid Biopsy and Cancer Interception Group, Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research, SCV003806415.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedresearch PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1somaticyes1not providednot provided1not providednot providednot provided

Last Updated: Jun 23, 2024